FDA Approved: MODAFINIL — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for modafinil filed by Bionpharma Inc. to market a generic wakefulness-promoting drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea-hypopnea Syndrome
• Shift Work Sleep Disorder

Drugs mentioned

• Modafinil (modafinil)

Snippet

SUPPL AP for MODAFINIL (MODAFINIL)